Purpose 31 Oxidative damage to the trabecular meshwork (TM) represents one of the 32 pathogenic mechanisms leading to primary open angle glaucoma (POAG).
Introduction
do genetic factors [8, 9] . Indeed, several studies have indicated that some 91 cases of glaucoma are hereditary, despite the fact that no single-hit POAG 92 gene has been identified, multiple genetic risk factors probably contribute to its 93 pathogenesis. Genes known to contribute to glaucoma are optineurin[10], 94 myocillin [11] , and TANK-binding kinase 1 (TBK1) [10] , furthermore, recent 95 genome-wide association studies have identified several single nucleotide 96 polymorphisms to be associated with POAG ( Table 1 ). In the general 97 population, these gene mutations are approximately >5-10% of all POAG 98 cases [12] . A genetically determined phenomenon that may be involved in the 99 pathogenesis of POAG, which could have a higher impact, is the lack of 100 glutathione transferase isoenzyme M1 (GSTM1). Indeed, several studies have 101 indicated the importance or otherwise of the GSTM1 null genotype, depending 102 on the patient populations studied [13] . GSTM1 catalyzes the detoxification of 103 electrophilic reactive oxygen species by conjugation with reduced glutathione. 104 Two polymorphic variants occur, i.e. normal-function (wild type) or loss-of-105 function due to homozygous deletion on both alleles (null genotype). The 106 existence of a single heterozygous deletion does not result in a loss of function 107 and is thus regarded as wild-type normal polymorphism. 108 Individual susceptibility to the adverse effects of ROS is modulated by genetic 109 polymorphisms of genes involved in their detoxification. This type of 110 polymorphism is only one among the complex pathogenic events leading to 111 glaucoma. Accordingly, adverse polymorphic variants of genes encoding for 112 antioxidant activities only slightly influence the risk of developing the disease; 113 the relative risk has been quantified as around 1.5 on comparing carriers of 114 adverse genetic variants with carriers of wild-type variants, a situation referred 115 to as 'low penetrance' [14, 15] . Nevertheless, these adverse genetic variants 116 are highly frequent in humans, their prevalence being 35-40% in Caucasians.
117
Evidence linking GSTM1 null polymorphisms to POAG exists in Asian but not in 
Results

216
GSTM1 polymorphism detection was achieved in all samples. 
293
In this scenario, the lack of the gene GSTM1 could have a pathogenetic role. invasive sampling (oral swab).
325
The GSTM1 null genotype is a risk factor because this genotype causes an Our research shows that, in the Caucasian population, the GSTM1 null 338 genotype is a risk factor in those affected by glaucoma, is more often observed 339 in patients who require surgery. In conclusion, according to our research, the 340 GSTM1null genotype in glaucoma patients is an indication for the use of both 341 topical and systemic antioxidants to protect both the trabecular meshwork and 342 the optic nerve head from oxidative injury. Further studies will be performed in 343 order to evaluate the impact of this type of therapy in these patients.
